For patients with head and neck squamous cell carcinoma, utilizing fluorodeoxyglucose-(FDG)-PET/CT imaging to assess their response to chemoradiation significantly increases the accuracy in ...
A new strategy that combines two types of PET scans can guide personalized radiotherapy for head and neck cancers, according ...
A first-in-class peptide-based PET tracer, 18 F-AlF-NOTA-PCP2, can effectively measure PD-L1 expression in patients with head and neck cancers, outperforming the conventional tracer 18 F-FDG. 18 F-AlF ...
Tumor hypoxia on 18F-fluoromisonidazole (FMISO) positron emission tomography (PET) may serve as a reliable clinical biomarker of distant metastasis risk for patients with head and neck squamous cell ...
A novel AI approach can accurately detect six different types of cancer on whole-body PET/CT scans, according to research presented at the 2024 Society of Nuclear Medicine and Molecular Imaging Annual ...
Patients who have a higher risk of head and neck cancer recurrence can expect more — and sooner — monitoring of their disease. A mouthwash-based test could lend insight into which patients with head ...
Cervical lymphadenopathy presents a shared anatomic challenge for clinicians, yet it serves as the divergent starting point for two distinct therapeutic pathways: Hodgkin’s lymphoma (HL) and ...